(Q46715188)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324909%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324909%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324909%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Mario Pirisi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324909%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Carlo Fabris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324909%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Carlo Smirne

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324909%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Pierluigi Toniutto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324909%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Cosimo Colletta

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324909%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Rachele Rapetti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324909%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Rosalba Minisini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324909%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Edmondo Falleti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324909%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324909%20AND%20SRC:MED&resulttype=core&format=json

Clinical Chemistry and Laboratory Medicine

3 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324909%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324909%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324909%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

253-259

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324909%20AND%20SRC:MED&resulttype=core&format=json

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

Progression of fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

Non-invasive diagnosis of cirrhosis and the natural history of its complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

The diagnostic value of liver biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

Sources of variability in histological scoring of chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

Detection assessment and monitoring of hepatic fibrosis: biochemistry or biopsy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

Noninvasive measures of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

Evaluation of liver fibrosis: a concise review

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

A novel panel of blood markers to assess the degree of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

Performance of serum marker panels for liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

Hepatitis C: a review for primary care physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

Plasma clearance of intravenously injected aspartate aminotransferase isozymes: evidence for preferential uptake by sinusoidal liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.051

21 January 2018

Identifiers

DOI

10.1515/CCLM.2008.051

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18324909%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference